Review article · 2021 · Open access
Pattern recognition receptors in health and diseases
Signal Transduction and Targeted Therapy, 6(1), 291 · Published 3 August 2021 · DOI 10.1038/s41392-021-00687-0
In brief
“Pattern recognition receptors in health and diseases” is a 2021 review article by Danyang Li and Minghua Wu, published in Signal Transduction and Targeted Therapy. OpenAlex counts 2,161 citations as of 16 November 2026, which puts it in the top 1% of works published in 2021 by citations. It is open access under a CC BY licence: the full text is free to read at Signal Transduction and Targeted Therapy.
- Citations
- 2,161
- Most cited in
- 2025 (634)
- Field-weighted impact
- 24.51
- References
- 496
- Authors
- 2
Abstract
Pattern recognition receptors (PRRs) are a class of receptors that can directly recognize the specific molecular structures on the surface of pathogens, apoptotic host cells, and damaged senescent cells. PRRs bridge nonspecific immunity and specific immunity. Through the recognition and binding of ligands, PRRs can produce nonspecific anti-infection, antitumor, and other immunoprotective effects. Most PRRs in the innate immune system of vertebrates can be classified into the following five types based on protein domain homology: Toll-like receptors (TLRs), nucleotide oligomerization domain (NOD)-like receptors (NLRs), retinoic acid-inducible gene-I (RIG-I)-like receptors (RLRs), C-type lectin receptors (CLRs), and absent in melanoma-2 (AIM2)-like receptors (ALRs). PRRs are basically composed of ligand recognition domains, intermediate domains, and effector domains. PRRs recognize and bind their respective ligands and recruit adaptor molecules with the same structure through their effector domains, initiating downstream signaling pathways to exert effects. In recent years, the increased researches on the recognition and binding of PRRs and their ligands have greatly promoted the understanding of different PRRs signaling pathways and provided ideas for the treatment of immune-related diseases and even tumors. This review describes in detail the history, the structural characteristics, ligand recognition mechanism, the signaling pathway, the related disease, new drugs in clinical trials and clinical therapy of different types of PRRs, and discusses the significance of the research on pattern recognition mechanism for the treatment of PRR-related diseases.
Cite this paper
Formatted from the catalogue record. Check names, capitals and page numbers against the paper before you submit.
APA 7
Li, D., & Wu, M. (2021). Pattern recognition receptors in health and diseases. Signal Transduction and Targeted Therapy, 6(1), 291. https://doi.org/10.1038/s41392-021-00687-0
MLA 9
Li, Danyang, and Minghua Wu. “Pattern recognition receptors in health and diseases.” Signal Transduction and Targeted Therapy, vol. 6, no. 1, 2021, p. 291. https://doi.org/10.1038/s41392-021-00687-0.
Chicago
Li, Danyang and Minghua Wu. 2021. “Pattern recognition receptors in health and diseases.” Signal Transduction and Targeted Therapy 6 (1): 291. https://doi.org/10.1038/s41392-021-00687-0.
Harvard
Li, D. and Wu, M. (2021) ‘Pattern recognition receptors in health and diseases’, Signal Transduction and Targeted Therapy, 6(1), p. 291. doi:10.1038/s41392-021-00687-0.
IEEE
D. Li and M. Wu, “Pattern recognition receptors in health and diseases,” Signal Transduction and Targeted Therapy, vol. 6, no. 1, p. 291, 2021, doi: 10.1038/s41392-021-00687-0.
BibTeX
@article{li2021pattern,
title = {{Pattern recognition receptors in health and diseases}},
author = {Li, Danyang and Wu, Minghua},
journal = {Signal Transduction and Targeted Therapy},
year = {2021},
volume = {6},
number = {1},
pages = {291},
doi = {10.1038/s41392-021-00687-0},
url = {https://doi.org/10.1038/s41392-021-00687-0}
}
Download for a reference manager: BibTeX (.bib) · RIS for Zotero, Mendeley and EndNote (.ris)
Citations by year
| Year | Citations | Share of the best year |
|---|---|---|
| 2021 | 14 | |
| 2022 | 190 | |
| 2023 | 372 | |
| 2024 | 500 | |
| 2025 | 634 | |
| 2026 | 451 |
Its field-weighted citation impact is 24.51: it has been cited 24.51 times as often as the average work of the same field, type and year (1.00 is the world average).
Topic and keywords
Life Sciences › Immunology and Microbiology › Immunology › Immune Response and Inflammation
- pattern recognition receptors
- innate immunity
- Toll-like receptors
- NOD-like receptors
- RIG-I-like receptors
- C-type lectin receptors
- AIM2-like receptors
- ligand recognition
Work with this paper
Most-cited papers in Immunology and Microbiology
- Cleavage of Structural Proteins during the Assembly of the Head of Bacteriophage T4Ulrich K. Laemmli · Nature · 1970 · 249,784 citations
- Atherosclerosis — An Inflammatory DiseaseRussell Ross · New England Journal of Medicine · 1999 · 21,957 citations
- Continuous cultures of fused cells secreting antibody of predefined specificityGeorges Köhler, César Milstein · Nature · 1975 · 17,450 citations
- Inflammation and cancerLisa M. Coussens, Zena Werb · Nature · 2002 · 15,462 citations
- Dendritic cells and the control of immunityJacques Banchereau, Ralph M. Steinman · Nature · 1998 · 14,526 citations
Questions about this paper
How do I cite this paper in APA style?
Li, D., & Wu, M. (2021). Pattern recognition receptors in health and diseases. Signal Transduction and Targeted Therapy, 6(1), 291. https://doi.org/10.1038/s41392-021-00687-0
How many times has this paper been cited?
2,161 times, according to OpenAlex on 16 November 2026. Google Scholar and Scopus count different sets of sources, so their numbers differ.
Is this paper free to read?
Yes. It is open access at Signal Transduction and Targeted Therapy: sign in and open the PDF from this page.
Who wrote this paper?
Danyang Li, Minghua Wu.
What is the DOI of this paper?
10.1038/s41392-021-00687-0, permanently at https://doi.org/10.1038/s41392-021-00687-0. Sign in and open it from this page.
Bibliographic data from OpenAlex (CC0), last checked 16 November 2026. ResearchGuru does not host this paper; once you are signed in, the links open it at the publisher or the repository that does.